Altay Therapeutics

Recent Finacing

Equity

Recent Raise

$3M

Altay Therapeutics develops small-molecule inhibitors of disease-causing transcription factors using a proprietary platform combining biochemical assays, computational biology, and chemoproteomics, advancing DUX4 inhibitors for FSHD.

Founded 2019

California, United States

1-10

Private

altaytherapeutics.com

Highlights

Focus Areas

Biotechnology

Health Care

Life Science

Therapeutics

Recent Investors

Financials

$3M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Altay Therapeutics.